Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer

Results of a phase I–II study of adjuvant concurrent carboplatin and accelerated radiotherapy for triple negative breast cancer

Purpose: To determine feasibility and explore the clinical efficacy of concurrent radiotherapy and carboplatin as adjuvant treatment of triple negative breast cancer (TNBC). Patients and Methods: Women with Stage I-II TNBC were treated after surgery in a phase I–II prospective trial [NCT01289353]. W...

Full description

Bibliographic Details
Main Authors: Silvia C. Formenti, Encouse B. Golden, Judith D. Goldberg, Xiaochun Li, Jessica Taff, Maria B. Fenton-Kerimian, Sharanya Chandrasekhar, Sandra Demaria, Yelena Novik
Format: Article
Language:English
Published: Taylor & Francis Group 2017-03-01
Series:OncoImmunology
Subjects:
adjuvant treatment
chemo-radiation
clinical trial
immunogenic cell death
triple negative breast cancer
tumor-infiltrating lymphocytes
Online Access:http://dx.doi.org/10.1080/2162402X.2016.1274479

Internet

http://dx.doi.org/10.1080/2162402X.2016.1274479

Similar Items